Nathalie Dubois-Stringfellow
CIK 1947007 · SVP-CHIEF DEVELOPMENT OFFICER · last filed 2026-05-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
22
Lifetime Open-Market Net
-$89.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SANGAMO THERAPEUTICS, INC (SGMO) Delisted | SVP-CHIEF DEVELOPMENT OFFICER | 332,769 | $0.18 | $59.1K | -$89.2K | 21 | 2026-04-23 |
Recent Filings · Page 2 of 3
22 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-04-24 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Tax (F) | −31,866 | -$24.7K | EDGAR |
| 2025-02-26 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Mixed | +116,695 | -$3.2K | EDGAR |
| 2025-01-24 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Tax (F) | −129,593 | -$149.0K | EDGAR |
| 2024-11-26 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Tax (F) | −3,295 | -$6.3K | EDGAR |
| 2024-08-27 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Tax (F) | −3,295 | -$2.8K | EDGAR |
| 2024-05-29 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Tax (F) | −3,295 | -$2.0K | EDGAR |
| 2024-02-27 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Tax (F) | −10,484 | -$11.8K | EDGAR |
| 2024-01-24 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Grant (A) | +712,500 | $0 | EDGAR |
| 2023-11-28 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Tax (F) | −1,462 | -$559 | EDGAR |
| 2023-08-29 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Tax (F) | −1,462 | -$1.1K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.